Salesforce Shares Tumble Despite In-Line Forecast as Organic Growth Concerns Mount

Salesforce's fiscal 2027 revenue forecast met expectations, but the stock fell as the guidance implied slower organic growth of around 7.5% after accounting for its recent acquisition.

This disappointment stems from investors' pre-existing concerns, fueled by a significant stock price drop over the past year and fierce competition in the AI space, especially from Microsoft.

To regain investor confidence, Salesforce must now prove it can accelerate organic growth through its AI product, Agentforce, and its data capabilities enhanced by the Informatica acquisition.

Salesforce recently announced a revenue forecast that met market expectations, yet its stock price fell in after-hours trading. This seemingly contradictory reaction reveals a deeper story about investor expectations in the age of AI.

The core of the issue lies in the difference between reported growth and organic growth. Salesforce's forecast for fiscal year 2027 suggests a headline growth of about 10-11%. However, this includes a roughly 3% boost from its recent acquisition of Informatica. When you strip that away, the company's underlying, or organic, growth is closer to 7.5%. In an era where investors are looking for explosive growth driven by AI, this more modest figure was seen as a disappointment.

This sentiment was amplified by pre-existing conditions. First, Salesforce's stock had already fallen by over 37% in the year leading up to the announcement. This sharp decline, known as multiple compression, means investors' patience was thin. They weren't looking for an 'in-line' report; they were looking for a clear sign of a powerful turnaround.

Second, the competitive landscape has shifted dramatically. A recent survey of Chief Information Officers (CIOs) showed that Microsoft's AI tool, Copilot, is being adopted far more widely than Salesforce's Agentforce. With overall IT budgets growing cautiously, companies are reallocating funds to the perceived AI winners. This puts immense pressure on Salesforce to prove its AI products can capture a significant share of corporate spending.

Of course, Salesforce presented its own strong points. The company highlighted a massive backlog of contracted future revenue (RPO), impressive growth in its Agentforce AI product, and a new $50 billion stock buyback program to reward shareholders. This creates a narrative of 'certainty of value.' However, the market is currently more interested in 'certainty of growth.' Until Salesforce can demonstrate that its AI strategy is translating into accelerated organic growth, investors are likely to remain cautious.

Organic Growth: Growth a company achieves through its own business activities, excluding growth from acquisitions or mergers.
RPO (Remaining Performance Obligation): A key metric for subscription-based companies, representing the total amount of contracted future revenue that has not yet been recognized.
Multiple Compression: When a company's stock price falls even as its earnings remain stable or grow, leading to a lower valuation multiple (like the Price-to-Sales ratio).

Salesforce Shares Tumble Despite In-Line Forecast as Organic Growth Concerns Mount

Salesforce's fiscal 2027 revenue forecast met expectations, but the stock fell as the guidance implied slower organic growth of around 7.5% after accounting for its recent acquisition.

This disappointment stems from investors' pre-existing concerns, fueled by a significant stock price drop over the past year and fierce competition in the AI space, especially from Microsoft.

To regain investor confidence, Salesforce must now prove it can accelerate organic growth through its AI product, Agentforce, and its data capabilities enhanced by the Informatica acquisition.

Organic Growth: Growth a company achieves through its own business activities, excluding growth from acquisitions or mergers.
RPO (Remaining Performance Obligation): A key metric for subscription-based companies, representing the total amount of contracted future revenue that has not yet been recognized.
Multiple Compression: When a company's stock price falls even as its earnings remain stable or grow, leading to a lower valuation multiple (like the Price-to-Sales ratio).